Financial Performance - In the first half of 2025, the company's operating revenue was 581.57 million yuan, an increase of 9.18% year-on-year [1] - The net profit attributable to shareholders was -15.75 million yuan, a decline of 341.23% compared to the same period last year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -18.49 million yuan, a decrease of 577.04% year-on-year [1] - The basic earnings per share were -0.043 yuan, down 338.89% from the previous year [1] - The company's total assets at the end of the reporting period were 1.64 billion yuan, a decrease of 4.72% from the end of the previous year [1] Profitability Metrics - The gross profit margin for the first half of 2025 was 12.60%, down 4.13 percentage points year-on-year [2] - The net profit margin was -2.95%, a decrease of 4.33 percentage points compared to the same period last year [2] Expense Analysis - The company's period expenses amounted to 78.35 million yuan, an increase of 3.28 million yuan year-on-year [2] - The period expense ratio was 13.47%, a decrease of 0.62 percentage points from the previous year [2] - Sales expenses increased by 19.42% year-on-year, while management expenses decreased by 8.80% [2] Corporate Governance - The chairman of the company, Liao Xuejin, has seen a continuous salary reduction over the past three years, with compensation of 3.93 million yuan in 2021, 3.25 million yuan in 2022, 1.38 million yuan in 2023, and 1.30 million yuan in 2024 [3] - Liao Xuejin has extensive experience in various leadership roles across multiple companies, including HL CORP (USA) and several subsidiaries in China [4][5] Company Overview - Shenzhen Xinlong Health Industry Development Co., Ltd. was established on October 28, 1991, and went public on January 12, 2007 [5] - The company specializes in the research, production, and sales of bicycle parts, sports equipment, rehabilitation aids, and aluminum extrusion products [5]